Tag: diabetes
Diabetes puzzle is more than sugar
Sri Ramakrishna Hospital has put the spotlight on the hidden triggers of diabetes—factors beyond sugar that silently increase risk for thousands. Through expert insights,...
MrMed expands reach with Bengaluru cold-chain hub
MrMed, an online super-specialty pharmacy, has opened a cold-chain distribution hub in Bengaluru. The new facility strengthens the company’s ability to deliver temperature-sensitive medicines...
Heart disease risk increases for U.S. immigrants the longer they live...
Foreign born immigrants to the United States have a lower risk of cardiovascular disease than their U.S.-born counterparts; however, that advantage diminishes the longer...
Gerresheimer & Portal to commercialize Prime Nexus reusable autoinjector
Gerresheimer, a system and solution provider and a global partner for the pharma, biotech and cosmetic industries, has announced that it will further expand...
Experts say small changes in nutrition can make a big difference
Living a healthy lifestyle does not need drastic changes or expensive supplements. Small, regular changes practiced consistently are enough for long-term benefits. The way...
Patient with life-threatening conditions saved after high-risk heart surgery
In a rare and inspiring medical success, a 54-year-old Delhi resident battling multiple serious health problems, including kidney failure, heart disease, diabetes, and past...
The Swedish Rheumatism Association launches label for easy-to-handle products
The Swedish Rheumatism association is launching a product label for packaging and products that have been tested and certified as easy to use. This...
Lilly launches Mounjaro for obesity and type 2 diabetes
Eli Lilly and Company (India) have announced the launch of Mounjaro in single-dose vial presentation following the marketing authorization from the Central Drugs Standard...
100x Ayurveda’s babycorn silk extract
Pune-based Kay Bee Bio Organics is the parent company of 100x Ayurveda. Kay Bee primarily exports 14-15 metric tons of babycorn daily to European...
Biocon launches formulation for diabetes and obesity
Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.)....